Natus Medical Inc. (BABY)
-NasdaqGS 15.03 
0.79(5.55%) 2:12PM EDT - Nasdaq Real Time Price
| Prev Close: | 14.24 |
|---|
| Open: | 14.48 |
|---|
| Bid: | 15.00 x 200 |
|---|
| Ask: | 15.03 x 100 |
|---|
| 1y Target Est: | 15.67 |
|---|
| Beta: | 1.04 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 14.26 - 15.10 |
|---|
| 52wk Range: | 9.65 - 15.10 |
|---|
| Volume: | 290,537 |
|---|
| Avg Vol (3m): | 118,792 |
|---|
| Market Cap: | 442.12M |
|---|
| P/E (ttm): | 115.69 |
|---|
| EPS (ttm): | 0.13 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Natus Medical Beats on Both Top and Bottom Linesat Motley Fool(Mon, May 20)
- Natus Medical Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Mon, May 20)
- Natus Medical Earnings: Everything You Must Know Nowat Wall St. Cheat Sheet(Mon, May 20)
- Natus Medical Incorporated Earnings Call scheduled for 8:00 am ET todayCCBN(Mon, May 20)
- InPlay: Natus Medical reports EPS in-line, beats on revs; reaffirms Q2 EPS guidance, revs guidance; raises FY13 EPS above consensus, reaffirms FY13 revs guidanceBriefing.com(Mon, May 20)
- Q1 2013 Natus Medical Incorporated Earnings Release - Before Market OpenCCBN(Mon, May 20)
- Natus Medical Announces 2013 First Quarter Financial ResultsBusiness Wire(Mon, May 20)
- NATUS MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitEDGAR Online(Mon, May 20)
- Alleged Patent Infringement by BSXZacks(Fri, May 17)
- Natus Medical to Hold 2013 First Quarter Financial Results Conference Call on May 20Business Wire(Fri, May 17)
- Neutral Rating Restated for CepheidZacks(Mon, May 13)
- NATUS MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitEDGAR Online(Tue, May 7)
- Natus to Delay Reporting of its First Quarter Financial ResultsBusiness Wire(Mon, May 6)
- Natus Medical upgraded at Raymond Jamestheflyonthewall.com(Thu, May 2)
- Natus to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference and the UBS Global Healthcare ConferenceBusiness Wire(Thu, May 2)
Key Statistics
| Forward P/E (1 yr): | 16.00 |
|---|
| P/S (ttm): | 1.43 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.84 |
|---|
| Quarterly EPS Est
(Mar-13)
: | 0.11 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | 0.76 |
|---|
Business Summary
Natus Medical Incorporated provides neurodiagnostic and newborn care products worldwide. The company offers healthcare products used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hear...
View More